New treatment hope for one of the deadliest childhood cancers

January 30, 2014, Cancer Research UK

Cancer Research UK doctors have launched a new trial which offers a new type of molecular radiotherapy - never before tested in children - for one of the deadliest childhood cancers.

The new treatment for uses radiotherapy which piggy-backs on a drug that naturally attaches itself to . Neuroblastoma is usually diagnosed in aged five and under, and the aggressive form of the disease remains very difficult to treat successfully.

Around 24 patients between 18 months and 18 years old will be treated in the LuDO neuroblastoma trial, at University College Hospital, London. The treatment will be delivered directly to the tumour in up to four courses once every eight weeks.

This treatment is effective in adults with other types, but this is the first time it has been tried in children with neuroblastoma.

Dr Mark Gaze, lead researcher on the study at the University College Hospital, said: "For far too long there has been too little progress for the patients I see every week. But in the last year we have finally seen new treatments become available, and new have been launched to tackle this terrible disease. We have real hope that this method of radiotherapy may be particularly effective and offer a new treatment option for these children."

Harri Norman from Newport, south Wales, was just two years old when he was diagnosed with neuroblastoma in March 2012. He underwent months of treatment including chemotherapy, surgery and even a and was just getting to the end of his treatment when the family received the devastating news that he had relapsed. In May last year he had to restart and now he has been put on the LuDO trial.

His father Mike, said: "It is terrifying when your child is sick and options start running out, so we jumped at the chance to be on the LuDO trial. Not only does it give Harri the best chance possible, but it also gives hope to other families whose children may benefit from this trial."

Neuroblastoma develops from nerve cells, and there are around 100 children diagnosed with this type of cancer each year in the UK. Despite the numbers of children surviving neuroblastoma rising from around 40 per cent in the 1980s to 60 per cent today, the majority of children have a high-risk form of the disease which is still very hard to cure.

Bettina Bungay-Balwah, Chief Executive of NCCA UK (Neuroblastoma Children's Cancer Alliance UK), said: "Far more work is needed to make improvements for children with neuroblastoma, and this trial goes a long way towards addressing this need. After funding the first phase of this trial, we are incredibly grateful that Cancer Research UK has provided the funds to continue this potentially life-saving work. We will continue to work with organisations focused on treating neuroblastoma to ensure that research continues in the future."

Kate Law, Cancer Research UK's director of clinical research, said: "Although three quarters of children with cancer are now cured compared with around a quarter in the late 1960s, more work is needed to discover better treatments. The LuDO neuroblastoma trial joins the BEACON neuroblastoma trial as vitally important steps towards better and kinder treatments for children with neuroblastoma."

Explore further: Redirecting our immune cells to help fight children's cancer

Related Stories

Redirecting our immune cells to help fight children's cancer

November 6, 2013
Immune cells, known as Natural Killer T cells, could be redirected to help fight the childhood cancer, neuroblastoma, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool ...

Beta-blockers may boost chemo effect in childhood cancer

May 22, 2013
Beta-blockers, normally used for high blood pressure, could enhance the effectiveness of chemotherapies in treating neuroblastoma, a type of children's cancer, according to a new study published in the British Journal of ...

Natural substance studied for future treatment of possibly incurable childhood cancer

January 13, 2014
In a recent doctoral thesis submitted at Karlstad University, Christina Fjæraa Alfredsson shows how the substance ellagic acid found in red berries and nuts, for instance, can stop cell division in cultivated cells from ...

New hope in the fight against childhood cancer

July 11, 2013
Cancer Research UK scientists at the University of Southampton are seeing positive results in a pre-clinical trial that could bring treatments for a particular aggressive form of childhood cancer closer to reality.

More than 33,000 childhood cancer survivors living in the UK

November 14, 2012
An estimated 33,000 long-term survivors of childhood cancer - the vast majority of whom are cured - will be living in the UK by the end of 2012, according to new figures from Cancer Research UK.

New therapy for childhood neuroblastoma proves feasible and safe

June 29, 2011
A new treatment option may soon be available for children with neuroblastoma according to research published in the July issue of The Journal of Nuclear Medicine. The study tested the principle that combined positron emission ...

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.